vs
Freshpet, Inc.（FRPT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Freshpet, Inc.的季度营收约是REPLIGEN CORP的1.4倍（$285.2M vs $197.9M），Freshpet, Inc.净利率更高（11.9% vs 6.7%，领先5.1%），REPLIGEN CORP同比增速更快（13.6% vs 8.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $2.1M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 12.9%）
Freshpet, Inc.是一家美国宠物食品企业，主打鲜制猫粮、狗粮产品，相关产品需冷藏保存，目前在纳斯达克上市，股票代码为FRPT。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FRPT vs RGEN — 直观对比
营收规模更大
FRPT
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出5.1%
8.6%
净利率更高
FRPT
高出5.1%
6.7%
自由现金流更多
RGEN
多$15.5M
$2.1M
两年增速更快
RGEN
近两年复合增速
12.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $285.2M | $197.9M |
| 净利润 | $33.8M | $13.3M |
| 毛利率 | 43.3% | 52.5% |
| 营业利润率 | 15.6% | 9.0% |
| 净利率 | 11.9% | 6.7% |
| 营收同比 | 8.6% | 13.6% |
| 净利润同比 | 86.6% | 143.9% |
| 每股收益（稀释后） | $0.71 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRPTRGEN
| Q4 25 | $285.2M | $197.9M | ||
| Q3 25 | $288.8M | $188.8M | ||
| Q2 25 | $264.7M | $182.4M | ||
| Q1 25 | $263.2M | $169.2M | ||
| Q4 24 | $262.7M | $174.1M | ||
| Q3 24 | $253.4M | $154.9M | ||
| Q2 24 | $235.3M | $154.1M | ||
| Q1 24 | $223.8M | $151.3M |
净利润FRPTRGEN
| Q4 25 | $33.8M | $13.3M | ||
| Q3 25 | $101.7M | $14.9M | ||
| Q2 25 | $16.4M | $14.9M | ||
| Q1 25 | $-12.7M | $5.8M | ||
| Q4 24 | $18.1M | $-30.3M | ||
| Q3 24 | $11.9M | $-654.0K | ||
| Q2 24 | $-1.7M | $3.3M | ||
| Q1 24 | $18.6M | $2.1M |
毛利率FRPTRGEN
| Q4 25 | 43.3% | 52.5% | ||
| Q3 25 | 39.5% | 53.2% | ||
| Q2 25 | 40.9% | 50.0% | ||
| Q1 25 | 39.4% | 53.6% | ||
| Q4 24 | 42.5% | 26.1% | ||
| Q3 24 | 40.4% | 50.0% | ||
| Q2 24 | 39.9% | 49.8% | ||
| Q1 24 | 39.4% | 49.5% |
营业利润率FRPTRGEN
| Q4 25 | 15.6% | 9.0% | ||
| Q3 25 | 8.6% | 8.9% | ||
| Q2 25 | 6.7% | 7.6% | ||
| Q1 25 | -4.4% | 3.9% | ||
| Q4 24 | 7.4% | -17.7% | ||
| Q3 24 | 4.7% | -5.1% | ||
| Q2 24 | -0.7% | 1.0% | ||
| Q1 24 | 3.8% | 1.3% |
净利率FRPTRGEN
| Q4 25 | 11.9% | 6.7% | ||
| Q3 25 | 35.2% | 7.9% | ||
| Q2 25 | 6.2% | 8.2% | ||
| Q1 25 | -4.8% | 3.4% | ||
| Q4 24 | 6.9% | -17.4% | ||
| Q3 24 | 4.7% | -0.4% | ||
| Q2 24 | -0.7% | 2.2% | ||
| Q1 24 | 8.3% | 1.4% |
每股收益（稀释后）FRPTRGEN
| Q4 25 | $0.71 | $0.24 | ||
| Q3 25 | $1.86 | $0.26 | ||
| Q2 25 | $0.33 | $0.26 | ||
| Q1 25 | $-0.26 | $0.10 | ||
| Q4 24 | $0.35 | $-0.55 | ||
| Q3 24 | $0.24 | $-0.01 | ||
| Q2 24 | $-0.03 | $0.06 | ||
| Q1 24 | $0.37 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $278.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.2B | $2.1B |
| 总资产 | $1.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FRPTRGEN
| Q4 25 | $278.0M | $767.6M | ||
| Q3 25 | $274.6M | $748.7M | ||
| Q2 25 | $243.7M | $708.9M | ||
| Q1 25 | $243.7M | $697.2M | ||
| Q4 24 | $268.6M | $757.4M | ||
| Q3 24 | $274.6M | $784.0M | ||
| Q2 24 | $251.7M | $809.1M | ||
| Q1 24 | $257.9M | $780.6M |
总债务FRPTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FRPTRGEN
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.0B | $2.0B | ||
| Q2 24 | $995.8M | $2.0B | ||
| Q1 24 | $977.8M | $2.0B |
总资产FRPTRGEN
| Q4 25 | $1.8B | $2.9B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.6B | $2.9B | ||
| Q1 25 | $1.6B | $2.9B | ||
| Q4 24 | $1.6B | $2.8B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.5B | $2.9B | ||
| Q1 24 | $1.5B | $2.8B |
负债/权益比FRPTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $2.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 0.7% | 8.9% |
| 资本支出强度资本支出/营收 | 18.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.63× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $12.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流FRPTRGEN
| Q4 25 | $55.1M | $25.7M | ||
| Q3 25 | $66.8M | $48.1M | ||
| Q2 25 | $33.9M | $28.6M | ||
| Q1 25 | $4.8M | $15.0M | ||
| Q4 24 | $50.4M | $39.2M | ||
| Q3 24 | $56.1M | $49.3M | ||
| Q2 24 | $42.4M | $42.2M | ||
| Q1 24 | $5.4M | $44.7M |
自由现金流FRPTRGEN
| Q4 25 | $2.1M | $17.6M | ||
| Q3 25 | $31.6M | $43.4M | ||
| Q2 25 | $445.0K | $21.5M | ||
| Q1 25 | $-21.7M | $11.4M | ||
| Q4 24 | $-7.9M | $33.6M | ||
| Q3 24 | $22.1M | $42.3M | ||
| Q2 24 | $-5.9M | $37.4M | ||
| Q1 24 | $-41.1M | $36.4M |
自由现金流率FRPTRGEN
| Q4 25 | 0.7% | 8.9% | ||
| Q3 25 | 10.9% | 23.0% | ||
| Q2 25 | 0.2% | 11.8% | ||
| Q1 25 | -8.2% | 6.8% | ||
| Q4 24 | -3.0% | 19.3% | ||
| Q3 24 | 8.7% | 27.3% | ||
| Q2 24 | -2.5% | 24.3% | ||
| Q1 24 | -18.3% | 24.0% |
资本支出强度FRPTRGEN
| Q4 25 | 18.6% | 4.1% | ||
| Q3 25 | 12.2% | 2.5% | ||
| Q2 25 | 12.6% | 3.9% | ||
| Q1 25 | 10.1% | 2.1% | ||
| Q4 24 | 22.2% | 3.2% | ||
| Q3 24 | 13.4% | 4.5% | ||
| Q2 24 | 20.5% | 3.1% | ||
| Q1 24 | 20.8% | 5.5% |
现金转化率FRPTRGEN
| Q4 25 | 1.63× | 1.93× | ||
| Q3 25 | 0.66× | 3.23× | ||
| Q2 25 | 2.07× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 2.78× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 0.29× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRPT
| Sales Channel Grocery Mass International And Digital | $228.4M | 80% |
| Sales Channel Pet Specialty And Club | $56.8M | 20% |
RGEN
暂无分部数据
